QUANTRO Therapeutics GmbH

BRIEF

published on 01/07/2025 at 14:35, 2 months 25 days ago

QUANTRO Therapeutics Reaches Milestone in Transcriptomic Drug Discovery

Biotech Showcase QUANTRO Therapeutics Transcriptomic Drug Discovery Multiplex-Screening QUANTROseq® Platform
PRESS RELEASE

published on 01/07/2025 at 14:30, 2 months 26 days ago

QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery with first successful simultaneous 10-target multiplex-screening
QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery with first successful simultaneous 10-target multiplex-screening. CEO Dr. Michael Bauer to attend industry events in San Francisco

Biotech Showcase QUANTRO Therapeutics Transcriptomic Drug Discovery Multiplex-Screening WuXi Global Forum
BRIEF

published on 10/24/2024 at 09:35, 5 months 9 days ago

QUANTRO Therapeutics and IMP Form Research Alliance for Drug Discovery

Drug Discovery Cancer Therapy QUANTRO Therapeutics IMP Collaboration Transcription Factor
PRESS RELEASE

published on 10/24/2024 at 09:30, 5 months 9 days ago

QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery
QUANTRO Therapeutics partners with IMP to advance transcriptomic drug discovery. Strategic collaboration to explore transcription factors' functions for cancer therapies

QUANTRO Therapeutics Transcription Factors IMP Transcriptomic Drug Discovery Cancer Therapies
BRIEF

published on 08/06/2024 at 10:05, 7 months 27 days ago

QUANTRO Therapeutics Secures Key Austrian Research Grant to Advance Platform Development

Drug Discovery QUANTRO Therapeutics FFG Grant Transcriptomic Platform Multiplexing
PRESS RELEASE

published on 08/06/2024 at 10:00, 7 months 27 days ago

QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform
QUANTRO Therapeutics secures Austrian research grant to accelerate cutting-edge platform development, enabling multiplex target screening in drug discovery

Drug Discovery QUANTRO Therapeutics Austrian Research Grant Transcriptomic Discovery Platform Multiplexing Capabilities
BRIEF

published on 06/04/2024 at 23:12, 9 months 27 days ago

QUANTRO Therapeutics Reaches Milestone in Collaboration with Boehringer Ingelheim

Cancer Treatments R&D Collaboration Boehringer Ingelheim QUANTRO Therapeutics Transcription Factors
PRESS RELEASE

published on 06/04/2024 at 23:07, 9 months 27 days ago

QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments
QUANTRO Therapeutics achieves key milestone in collaboration with Boehringer Ingelheim for first-in-class cancer treatments using proprietary technology

Cancer Treatments Boehringer Ingelheim QUANTRO Therapeutics Transcription Factors R&D Program
PRESS RELEASE

published on 04/04/2023 at 09:30, 1 year 11 months ago

QUANTRO Therapeutics appoints Industry Expert Dr. Michael Bauer as Chief Executive Officer

Published on 04/02/2025 at 14:00, 33 minutes ago

Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Published on 04/02/2025 at 14:00, 33 minutes ago

Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City
Published on 04/02/2025 at 13:35, 58 minutes ago

NuRAN Announces 20 New Sites in March
Published on 04/02/2025 at 13:30, 1 hour 3 minutes ago

The Fresh Factory Completes US$3 Million Non-Brokered Private Placement
Published on 04/02/2025 at 13:00, 1 hour 33 minutes ago

Snipp Interactive Announces Significant Six Figure Renewal with the European Healthcare Division of a Leading American Multinational Conglomerate

View all ACCESSWIRE

Published on 04/02/2025 at 13:53, 39 minutes ago

tick Trading Software AG organizes succession of CEO
Published on 04/02/2025 at 12:45, 1 hour 48 minutes ago

Director/PDMR Shareholding
Published on 04/02/2025 at 12:43, 1 hour 49 minutes ago

Aquis Stock Exchange - Application for Admission to Trading
Published on 04/02/2025 at 12:39, 1 hour 54 minutes ago

Hardman & Co Research on Apax Global Alpha (APAX): Jam yesterday, and tomorrow, but not today
Published on 04/02/2025 at 12:36, 1 hour 56 minutes ago

Dalata Hotel Group PLC: HOL-Holding(s) in Company*

View all EQS

Published on 04/01/2025 at 17:45, 20 hours 48 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 04/01/2025 at 12:31, 1 day 2 hours ago

Statement of transactions in own shares from March 24, 2025 to March 28, 2025
Published on 04/01/2025 at 08:30, 1 day 6 hours ago

Cie du Bois Sauvage: Buy back of own shares – week from 24/03/2025 to 28/03/2025
Published on 03/31/2025 at 19:42, 1 day 18 hours ago

Availability of Safran’s 2024 Universal Registration Document (URD)
Published on 03/31/2025 at 19:00, 1 day 19 hours ago

Eiffage strengthens its expertise in the offshore energy market with the acquisition of HSM Offshore Energy, a reputable Dutch based EPCIC company

View all LES ECHOS COMFI WIRE

News